149
Active Trials
46
Phase 1
54
Phase 2
75
Phase 3
13
Therapeutic Areas
Portfolio Concentration: 72% of active trials in Oncology
Oncology
107 active / 374 total
Solid Tumor (Advanced)
15 active
4 Ph3
94 total since 2015
NSCLC
13 active
7 Ph3
38 total since 2015
Multiple Myeloma
12 active
6 Ph3
32 total since 2015
Non-Hodgkin Lymphoma
10 active
3 Ph3
34 total since 2015
Melanoma
6 active
3 Ph3
26 total since 2015
MDS
6 active
5 Ph3
15 total since 2015
Renal Cell Carcinoma
5 active
3 Ph3
12 total since 2015
SCLC
4 active
1 Ph3
8 total since 2015
Colorectal Cancer
4 active
2 Ph3
7 total since 2015
Myelofibrosis
4 active
2 Ph3
7 total since 2015
Bladder Cancer
4 active
3 Ph3
6 total since 2015
Pancreatic Cancer
4 active
1 Ph3
6 total since 2015
Hepatocellular Carcinoma
3 active
2 Ph3
9 total since 2015
Hematologic Malignancies
2 active
21 total since 2015
Lung Cancer (General)
2 active
13 total since 2015
Prostate Cancer
2 active
1 Ph3
8 total since 2015
Breast Cancer
2 active
5 total since 2015
Ovarian Cancer
2 active
2 total since 2015
AML
2 active
2 total since 2015
Head and Neck Cancer
1 active
5 total since 2015
Mesothelioma
1 active
3 total since 2015
Esophageal Cancer
1 active
1 Ph3
2 total since 2015
ALL
1 active
1 Ph3
2 total since 2015
Cervical Cancer
1 active
1 total since 2015
Brain Tumor
0 active
5 total since 2015
Gastric Cancer
0 active
4 total since 2015
Glioblastoma
0 active
4 total since 2015
Hodgkin Lymphoma
0 active
2 total since 2015
Sarcoma
0 active
1 total since 2015
CNS
20 active / 25 total
Immunology
19 active / 121 total
Lupus
6 active
2 Ph3
17 total since 2015
Rheumatoid Arthritis
5 active
2 Ph3
25 total since 2015
Psoriasis
4 active
4 Ph3
23 total since 2015
Psoriatic Arthritis
3 active
3 Ph3
5 total since 2015
Ankylosing Spondylitis
1 active
23 total since 2015
Crohn's Disease
0 active
13 total since 2015
Ulcerative Colitis
0 active
9 total since 2015
Atopic Dermatitis
0 active
3 total since 2015
IBD
0 active
3 total since 2015
Cardiovascular
10 active / 37 total
Myocardial Infarction
8 active
3 Ph3
15 total since 2015
Heart Failure
1 active
12 total since 2015
Hypertrophic Cardiomyopathy
1 active
3 total since 2015
Thrombosis
0 active
2 total since 2015
Coronary Artery Disease
0 active
2 total since 2015
Stroke
0 active
2 total since 2015
Atrial Fibrillation
0 active
1 total since 2015
Respiratory
3 active / 9 total
Urology
2 active / 6 total
Gastrointestinal
1 active / 5 total
Infectious Disease
0 active / 12 total
Metabolic
0 active / 11 total
Hepatology
0 active / 5 total
Dermatology
0 active / 1 total
Musculoskeletal
0 active / 1 total
Renal
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)